Work

A phase II, open-label, multi-arm study of novel combinations of immunotherapies or DDR inhibitors in platinum-refractory, extensive disease small-cell lung cancer (ED-SCLC): BALTIC.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps8585

Authors: Joachim Von Pawel, Ihor Vynnychenko, Haiyi Jiang, Yifan Huang, Phillip A. Dennis

Institutions: Asklepios Fachkliniken München-Gauting, Sumy State University

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890882848

Cites:

Cited by: 8

Related to: 10